MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 05-23-2026
Chembio Diagnostics Total Inventories 2011-2026 | CEMI
Annual Total Inventories Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.72 M | 12.9 M | 12.5 M | 9.6 M | 7.85 M | 4.42 M | 3.34 M | 3.58 M | 3.64 M | 3.19 M | 2.49 M | 2.3 M | 1.35 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.9 M | 1.35 M | 5.76 M |
Quarterly Total Inventories Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 8.47 M | 11.3 M | 11.8 M | 12.9 M | 16.8 M | 15.7 M | 14.7 M | 12.5 M | 12.4 M | 14.1 M | 10.9 M | 9.6 M | 8.41 M | 9.07 M | 9.86 M | 7.85 M | 5.98 M | 6.35 M | 5.8 M | 4.42 M | 5.24 M | 4.99 M | 3.75 M | 3.34 M | 3.43 M | 3.48 M | 3.38 M | 3.58 M | 3.01 M | 3.78 M | 3.7 M | 3.64 M | 3.98 M | 4.08 M | 3.6 M | 3.19 M | 3.75 M | 3.85 M | 2.6 M | 2.49 M | 3.04 M | 3.14 M | 2.71 M | 2.3 M | 2.59 M | 2.92 B | 2.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.92 B | 2.3 M | 68.4 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
Co-Diagnostics
CODX
|
992 K | $ 5.76 | 11.41 % | $ 7.66 M | USA |
 |
Castle Biosciences
CSTL
|
10.3 M | $ 21.6 | 5.93 % | $ 626 M | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
2.85 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
85.9 M | $ 133.06 | 4.75 % | $ 16.7 B | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 152.8 | 6.18 % | $ 12 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 23.12 | 3.63 % | $ 1.23 B | USA |
 |
Illumina
ILMN
|
564 M | $ 168.06 | -1.68 % | $ 26 B | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.79 | 2.29 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
387 M | - | - | $ 24.3 B |  Schweiz |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | - | - | $ 6.94 B | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 11.31 | 11.54 % | $ 1.45 B | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 185.79 | 3.29 % | $ 9.21 B | USA |
 |
Natera
NTRA
|
68.4 M | $ 222.1 | 4.84 % | $ 30.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.69 | 6.59 % | $ 434 M | USA |
 |
Senseonics Holdings
SENS
|
6.7 M | $ 7.01 | 4.32 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
15 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.49 M | - | - | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 260.97 | 0.79 % | $ 21.7 B | USA |
 |
Twist Bioscience Corporation
TWST
|
28.3 M | - | - | $ 4.42 B | USA |
 |
Thermo Fisher Scientific
TMO
|
5.42 B | $ 482.03 | 1.7 % | $ 182 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
191 M | $ 9.12 | 3.52 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 196.12 | 1.27 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |
 |
Waters Corporation
WAT
|
572 M | $ 376.47 | -0.87 % | $ 22.4 B | USA |